DATE: 2-3 June 2011

ORGANIZERS: Johns Hopkins Malaria Research Institute (JHMRI) and GlaxoSmithKline (GSK)

LOCATION: GlaxoSmithKline’s Medicines Development Campus Tres Cantos, Spain

GENERAL INFORMATION:

GlaxoSmithKline will host the third annual Johns Hopkins Malaria Research Institute Research Advances in Malaria conference at the GSK Medicines Development Campus in Tres Cantos, Spain on Thursday 2 June and Friday 3 June 2010. The two-day international meeting will address critical issues in malaria drug development from pre-clinical to clinical studies. The development of new drugs against novel targets is an urgent goal due to the ever increasing parasite resistance to existing drugs. GSK and JHMRI welcome abstract submissions for poster presentation and short talk consideration.  Researchers, students, and fellows are encouraged to participate in this meeting.

CONFIRMED SPEAKERS:

Iñigo Angulo-Barturen
GlaxoSmithKline, Spain

Thierry Diagana
Novartis Institute for Tropical Diseases,Singapore

Abdoulaye Djimde’
Howard Hughes Medical Institute, Malaria Research and Training Center, Mali

Chris Drakeley
London School of Hygiene and Tropical Medicine,England

Geoffrey Dow
Walter Reed Army Institute of Research, USA

David Fidock
Columbia University, USA

Ernesto Freire
Johns Hopkins University, USA

Francisco Javier Gamo-Benito
GlaxoSmithKline, Spain

Daniel Goldberg
Washington University, USA

Andrew Humberstone
Medicines for Malaria Ventures, Switzerland

Dennis Kyle
University of South Florida, USA

Maria Mota
University of Lisbon, Portugal

Oscar della Pasqua
GlaxoSmithKline, England

Hernando del Portillo
Barcelona Centre for International Health Research, Spain

Robert Sinden
Imperial College, England

Jonathan Vennerstrom
University of Nebraska, USA

Elizabeth Winzeler
Scripps Research Institute, USA

Nick White*
Wellcome Trust-Mahidol University, Thailand